160 related articles for article (PubMed ID: 34523293)
21. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
22. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid receptors in patients with congenital adrenal hyperplasia.
Saka N; Güven M; Baş F; Darendeliler F; Bundak R; Günöz H; Sultuybek G
J Pediatr Endocrinol Metab; 2000; 13(8):1101-7. PubMed ID: 11085188
[TBL] [Abstract][Full Text] [Related]
24. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
Lim YJ; Yong AB; Warne GL; Montalto J
J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
[TBL] [Abstract][Full Text] [Related]
25. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
Sólyom J
Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
[TBL] [Abstract][Full Text] [Related]
27. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
Sarafoglou K; Himes JH; Lacey JM; Netzel BC; Singh RJ; Matern D
Horm Res Paediatr; 2011; 75(1):19-25. PubMed ID: 20798478
[TBL] [Abstract][Full Text] [Related]
28. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
Verma S; Vanryzin C; Sinaii N; Kim MS; Nieman LK; Ravindran S; Calis KA; Arlt W; Ross RJ; Merke DP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
[TBL] [Abstract][Full Text] [Related]
29. Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy.
German A; Suraiya S; Tenenbaum-Rakover Y; Koren I; Pillar G; Hochberg Z
J Clin Endocrinol Metab; 2008 Dec; 93(12):4707-10. PubMed ID: 18782876
[TBL] [Abstract][Full Text] [Related]
30. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML; Hermos RJ
Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
[TBL] [Abstract][Full Text] [Related]
31. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
32. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
Török D; Eckhardt G; Sólyom J
Eur J Pediatr; 2003 Dec; 162(12):844-9. PubMed ID: 14648216
[TBL] [Abstract][Full Text] [Related]
33. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
Ghizzoni L; Bernasconi S; Virdis R; Vottero A; Ziveri M; Volta C; Iughetti L; Giovannelli G
Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
[TBL] [Abstract][Full Text] [Related]
35. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
36. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
[TBL] [Abstract][Full Text] [Related]
37. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
Riordan FA; Wood PJ; Wakelin K; Betts P; Clayton BE
Lancet; 1984 Mar; 1(8379):708-11. PubMed ID: 6143043
[TBL] [Abstract][Full Text] [Related]
38. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
39. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[TBL] [Abstract][Full Text] [Related]
40. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
